A CRISPR/Cas9-Engineered <i>ARID1A</i> -Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
Yuan‐Hung Lo(Princess Margaret Hospital), Calvin J. Kuo(Stratford University), Jonathan S. Weissman(Howard Hughes Medical Institute), Amanda T. Mah(Stanford Medicine), Chiung-Ying Chang(Stanford Medicine), Kevin S. Kolahi(Stanford Medicine), Christina Curtis(Chan Zuckerberg Initiative (United States)), Kasper Karlsson(Karolinska Institutet), Sunny J. Jones(Kallyope (United States)), Andrea Califano(Columbia University Irving Medical Center), Ajay Nair(Columbia University), Ilya Shmulevich(Institute for Systems Biology), Haian Fu(Emory University), Bahar Tercan(Institute for Systems Biology), Alexandra Sockell(Stanford Medicine), Teri A. Longacre(Palo Alto University), Jin Chen(Howard Hughes Medical Institute), Hang Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), A. Krokhotin(University of North Carolina at Chapel Hill), Walter D. Sobba(Stanford Medicine), Yuhong Du(Emory University), José A. Seoane(Stanford University)
Cited by 166
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
|Cell|2011|2.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Molecular Chaperones and Protein Quality Control
|Cell|2006|1.6k